Nutrition and breast cancer risk: Can an effect via insulin resistance be demonstrated?

Breast Cancer Research and Treatment

Volumn 38, Issue 3, 1996, Pages 239-246

  Stoll, Basil A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer etiology; Hyperinsulinemia; Insulin resistance; Macronutrients; Weight gain

Indexed keywords

ESTROGEN;

ANIMAL; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARBOHYDRATE INTAKE; DIETARY FIBER; DIETARY INTAKE; FAT INTAKE; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIFESTYLE; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; WEIGHT GAIN;

BREAST NEOPLASMS; DIETARY FATS; FEMALE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; OBESITY; RISK FACTORS;

EID: 0029865344     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806141     Document Type: Review

References (58)

1. Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM: Rising levels of estrogen receptor in breast cancer over two decades. Cancer 74:1601-1606, 1994
2. Stamler J: Epidemic obesity in the United States. Arch Int Med 153:1040-1044, 1993
3. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382-386, 1991
4. Zimmet PZ: Challenges in diabetes epidemiology: from West to the rest. Diabetes Care 15:232-252, 1992
5. Bruning PF, Bonfrer JMG, van Noord PAH, de Jong Bakker M, Nooijen WJ: Insulin resistance and breast cancer risk. Int J Cancer 52:511-516, 1992
6. Ballard-Barbash R, Schatzkin A, Taylor PR, Kahle LL: Association of change in body mass with breast cancer. Cancer Res 50:2152-2155, 1990
7. Berstein LM: Increased risk of breast cancer in women with central obesity: additional considerations. J Natl Cancer Inst 82:1943-1944, 1990
8. Folsom AR, Kaye SA, Prineas PJ, et al: Increased evidence of carcinoma of the breast associated with abdominal obesity in postmenopausal women. Am J Epidemiol 131:794-803, 1990
9. Schapira DV, Kumar NB, Lyman GH, Cox CE: Abdominal obesity and breast cancer risk. Ann Int Med 112:182-186, 1990
10. Beex LVAM: Metabolic diseases influencing prognosis. In: Stoll BA (ed) Breast Cancer Treatment and Prognosis. Blackwell Scientific, Oxford, 1986, pp 200-211
11. Laws A, Reaven GM: Insulin resistance and risk factors for coronary heart disease. Ballieres Clin Endocrinol Metab 7:1063-1070, 1993
12. Eckel RH: Insulin resistance: an adaptation for weight maintenance. Lancet 340:1542-1543, 1992
13. Smith U: Carbohydrates, fat, and insulin action. Am J Clin Nutr 59(3 suppl):686S-689S, 1994
14. Hansen BC: Genetics of insulin action. Ballieres Clin Endocrinol Metab 7:1033-1062, 1933
15. Zimmet PZ: Hyperinsulinemia - how innocent a by-stander? Diabetes Care 16(Suppl 3):56-70, 1993
16. Ballard-Barbash R: Anthropometry and breast cancer. Cancer 74:1090-1100, 1994
17. Kirschner MA, Samojlik E, Drejka M, et al: Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab 70:473-479, 1990
18. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH: Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 33:68-75, 1984
19. Leenen R, van der Kooy K, Seidell JC, et al: Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 78:1515-1520, 1994
20. Kopelman PG: Hormones and obesity. Ballieres Clin Endocrinol Metab 8:549-576, 1994
21. Stoll BA: Breast cancer: the obesity connection. Br J Cancer 69:799-801, 1994
22. Wajchenberg BL, Malerbi DA, Rocha MS, et al: Syndrome X: a syndrome of insulin resistance. Epidemiological and clinical evidence. Diabetes Metab Rev 10:19-29, 1994
23. Osborne CK, Bolan G, Monaco ME, Lippman ME: Hormone responsive human breast cancer in long term tissue culture. Proc Natl Acad Sci USA 73:4536-4540, 1978
24. Arteaga CL, Osborne CK: Growth inhibition of human breast cancer cells in vitro with an antibody against the Type 1 somatomedin receptor. Cancer Res 49:6237-6241, 1989
25. Cotterrill A, Holly J, Savage M: Current status of the insulin-like growth factors and their binding proteins. Growth Matters 9:7-10, 1992
26. Cullen KJ, Smith HS, Hill S, Rosen K, Lippman ME: Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51:4978-4985, 1991
27. Stewart AJ, Johnson MD, May FEB, Westley BR: Roles of IGFs and IGF1 receptor on the estrogen- stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178, 1990
28. Thorsen T, Lahooti H, Rasmussen M, Aakvaag A: Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth-stimulatory effect of IGF1. J Steroid Biochem Molec Biol 41:537-540, 1992
29. Vague P, Juhan Vague J, Chabert V, et al: Fat distribution and plasminogen activator inhibitor activity in non diabetic obese women. Metabolism 38:913- 915, 1989
30. Sumiyoshi K, Serizawa K, Urano T, et al: Plasminogen activator system in human breast cancer. Int J Cancer 50:345-348, 1992
31. Bouchet C, Spyratos F, Martin PM, et al: Prognostic value of uPA, PAI-1, and PAI-2 in breast carcinoma. Br J Cancer 69:398-405, 1994
32. Glass K, Hoover RN: Rising incidence of breast cancer: relationship to stage and receptor status. J Natl Cancer Inst 82:693-696, 1990
33. Di Fronzo G, Coradini D, Cappelletti V, et al: Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels. Anticancer Res 10:1699-1706, 1990
34. Nomura Y, Kanda K, Shigematsu T, et al: Relation between estrogen receptors and body weight in Japanese pre and postmenopausal breast cancer patients. Gann 72:469-469, 1981
35. Pascual MR, Lazo R, Fernandez L, Lage A: Clinical factors related to the presence of estrogen receptors in breast cancer: a prognostic stratification analysis. Neoplasma 29:453-461, 1982
36. Giuffrida D, Lupo L, LaPorta GA, et al: Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer 28:112-115, 1992
37. Schapira D, Kumar NB, Lyman GH, Cox CE: Obesity and body fat distribution and breast cancer prognosis. Cancer 67:523-528, 1991
38. Sellers TA, Potter JD, Folsom AR: Family history, body fat distribution, and the risk of breast cancer. N Engl J Med 327:958-959, 1992
39. Weisser B: Plasma insulin is correlated with blood pressure only in subjects with a family history of hypertension or diabetes. J Hypertens 11(suppl 5): S308-309, 1993
40. Prentice RL, Sheppard L: Dietary fat and cancer: consistency of the epidemiological data. Cancer Causes Control 1:81-97, 1990
41. Henson DE, Tarone RE: Involution and the etiology of breast cancer. Cancer 74:424-429, 1994
42. Pike MC, Krailo MD, Henderson BE, et al: Hormonal risk factors, breast tissue age, and the age-incidence of breast cancer. Nature 303:767-770, 1983
43. Marshall JA, Shetterly S, Hoag S, Hamman RF: Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. Diabetes Care 17:50-56, 1994
44. Storlien LH, James DE, Burleigh KM, et al: Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251:E576-583, 1986
45. Maron DJ, Fair FM, Haskell WL, et al: Saturated fat intake and insulin resistance in men with coronary artery disease. Circulation 84:2020-2027, 1991
46. Barnard RJ, Ugianskis EJ, Martin DA, Inkeles SB: Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 69:440-444, 1992
47. Ballard-Barbash R, Schatzkin A, Carter CL, et al: Body fat distribution and breast cancer in the Framingham study. J Natl Cancer Inst 82:286-290, 1990
48. Kopelman PG, White N, Pilkington TRE, et al: The effect of weight loss on sex steroid secretion and binding in massively obese women, Clin Endocrinol 15:113-116, 1981
49. Prentice R, Thompson D, Clifford C, et al: Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. J Natl Cancer Inst 82:129- 134, 1990
50. London SJ, Colditz GA, Stampfer MJ, et al: Prospective study of relative weight, height, and risk of breast cancer. J Am Med Assoc 262:2853-2858, 1989
51. Brinton LA, Swanson CA: Height and weight at various ages and risk of breast cancer. Am J Epidemiol 2:597-609, 1992
52. Greenwald P: National Cancer Institute cancer prevention and control research. Prev Med 22:642-660, 1993
53. Boyd NF: Nutrition and breast cancer. J Natl Cancer Inst 85:6-7, 1993
54. Chlebowski RT, Rose D, Buzzard JM, et al: Adjuvant dietary fat intake reduction in postmenopausal breast cancer patients. Breast Cancer Res Treat 20:73-84, 1991
55. Barnard RJ: Effects of life style modification on serum lipids. Arch Int Med 151:1389-1394, 1991
56. Lubin F, Wax Y, Modan B: Role of fat, animal protein, and dietary fiber in breast cancer etiology. J Natl Cancer Inst 77:605-611, 1986
57. Adlercreutz H: Western diet and Western diseases: some hormonal and biochemical mechanisms and association. Scand J Clin Lab Invest 50(suppl 201):3-23, 1990
58. Doll R, Payne P, Waterhouse J: Cancer incidence in five continents. A technical report, UICC. Springer Verlag, Berlin, 1966.